Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. Borghesani, L. Gervaso, C.A. Cella, L. Benini, D. Ciardiello, L. Algeri, A. Ferrero, C. Valenza, L. Guidi, MG. Zampino, F. Spada & N. Fazio. Promising targetable biomarkers in pancreatic neuroendocrine tumours. Expert Review of Endocrinology & Metabolism 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (21)
Diana Grace Varghese, Jaydira Del Rivero & Emily Bergsland. (2023) Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors. Cancers 15:14, pages 3712.
Crossref
Crossref
Anna Battistella, Stefano Partelli, Valentina Andreasi, Ilaria Marinoni, Diego Palumbo, Matteo Tacelli, Marco Schiavo Lena, Francesca Muffatti, Junaid Mushtaq, Gabriele Capurso, Paolo Giorgio Arcidiacono, Francesco De Cobelli, Claudio Doglioni, Aurel Perren & Massimo Falconi. (2022) Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Surgery 172:4, pages 1236-1244.
Crossref
Crossref
Noémie S. Minczeles, Casper H. J. van Eijck, Marjon J. van Gils, Marie-Louise F. van Velthuysen, Els J. M. Nieveen van Dijkum, Richard A. Feelders, Wouter W. de Herder, Tessa Brabander & Johannes Hofland. (2022) Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients. European Journal of Nuclear Medicine and Molecular Imaging 49:9, pages 3203-3214.
Crossref
Crossref
Anna Bryan Stensbøl, Jesper Krogh, Pernille Holmager, Marianne Klose, Peter Oturai, Andreas Kjaer, Carsten Palnæs Hansen, Birgitte Federspiel, Seppo W. Langer, Ulrich Knigge & Mikkel Andreassen. (2021) Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors. Diagnostics 11:11, pages 2030.
Crossref
Crossref
Bregtje C.M. Hermans, Judith de Vos-Geelen, Jules L. Derks, Loes Latten, Ing Han Liem, Jan Maarten van der Zwan, Ernst-Jan M. Speel, M. Wouter Dercksen & Anne-Marie C. Dingemans. (2021) Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin. Neuroendocrinology 111:11, pages 1111-1120.
Crossref
Crossref
Josep Darbà & Alicia Marsà. (2019) Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources. BMC Cancer 19:1.
Crossref
Crossref
Shao-Wei Gao, Chen-Song Huang, Xi-Tai Huang, Liu-Hua Chen, Wei Chen, Jian-Peng Cai & Xiao-Yu Yin. (2019) Ki-67 Index of 5% is Better Than 2% in Stratifying G1 and G2 of the World Health Organization Grading System in Pancreatic Neuroendocrine Tumors. Pancreas 48:6, pages 795-798.
Crossref
Crossref
Alessandra Pulvirenti, Deepthi Rao, Caitlin A. Mcintyre, Mithat Gonen, Laura H. Tang, David S. Klimstra, Martin Fleisher, Lakshmi V. Ramanathan, Diane Reidy-Lagunes & Peter J. Allen. (2019) Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. HPB 21:5, pages 612-618.
Crossref
Crossref
Enes Kaçmaz, Charlotte M. Heidsma, Marc G. H. Besselink, Koen M. A. Dreijerink, Heinz-Josef Klümpen, Elisabeth J. M. Nieveen van Dijkum & Anton F. Engelsman. (2019) Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8:3, pages 403.
Crossref
Crossref
Li Yu, Rongjie Zhao, Xufeng Han, Jiawei Shou, Liangkun You, Hanliang JiangXiaoyun Zhou, Zhen Liu, Hongming Pan & Weidong Han. (2019) Lymph node involvement in pancreatic neuroendocrine tumors: significance as a predictor of survival. Journal of Bio-X Research 2:1, pages 25-33.
Crossref
Crossref
Alexandra G. Lopez-Aguiar & Kenneth Cardona. (2018) ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology 25:S3, pages 826-827.
Crossref
Crossref
Yong Gao, Hao Gao, Guangfu Wang, Lingdi Yin, Wenbin Xu, Yunpeng Peng, Junli Wu, Kuirong Jiang & Yi Miao. (2018) A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms. Scientific Reports 8:1.
Crossref
Crossref
Alexandra G. Lopez-Aguiar, Cecilia G. Ethun, Lauren M. Postlewait, Kristen Zhelnin, Alyssa Krasinskas, Bassel F. El-Rayes, Maria C. Russell, Juan M. Sarmiento, David A. Kooby, Charles A. Staley, Shishir K. Maithel & Kenneth Cardona. (2017) Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease. Annals of Surgical Oncology 25:1, pages 290-298.
Crossref
Crossref
Mohsen Beheshti, Alireza Rezaee, Markus Raderer & Werner Langsteger. 2018. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging
85
109
.
Peng Liu, Xianbin Zhang, Yuru Shang, Lili Lu, Fei Cao, Min Sun, Zhaohui Tang, Brigitte Vollmar & Peng Gong. (2017) Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection. Oncotarget 8:51, pages 89245-89255.
Crossref
Crossref
Katelin A. Mirkin, Christopher S. Hollenbeak & Joyce Wong. (2017) Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm. Journal of Surgical Research 211, pages 206-214.
Crossref
Crossref
Mark Kidd, Lisa Bodei & Irvin M. Modlin. (2016) Chromogranin A. Current Opinion in Endocrinology, Diabetes & Obesity 23:1, pages 28-37.
Crossref
Crossref
Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas & George N. Zografos. (2016) Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?. Hormones 15:1, pages 15-22.
Crossref
Crossref
Lingaku Lee, Hisato Igarashi, Nao Fujimori, Masayuki Hijioka, Ken Kawabe, Yoshinao Oda, Robert T. Jensen & Tetsuhide Ito. (2015) Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. Japanese Journal of Clinical Oncology, pages hyv143.
Crossref
Crossref
Joo Young Kim, Ki-Suk Kim, Kyung-Jo Kim, In Ja Park, Jong Lyul Lee, Seung-Jae Myung, Yangsoon Park, Young Soo Park, Chang Sik Yu, Jin Cheon Kim, Eunsil Yu, Hyeung-Jin Jang & Seung-Mo Hong. (2015) Non-L-cell Immunophenotype and Large Tumor Size in Rectal Neuroendocrine Tumors Are Associated With Aggressive Clinical Behavior and Worse Prognosis. American Journal of Surgical Pathology 39:5, pages 632-643.
Crossref
Crossref
Thomas Curran, Barbara A. Pockaj, Richard J. Gray, Thorvardur R. Halfdanarson & Nabil Wasif. (2014) Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection. Journal of Gastrointestinal Surgery 19:1, pages 152-160.
Crossref
Crossref